SCYNEXIS to Reduce Outstanding Shares to 9.9M via 1-for-8 Reverse Split
SCYX•SCYNEXIS will execute a 1-for-8 reverse stock split at 4:05 p.m. ET on May 29, 2026, reducing its shares outstanding from 79.5 million to 9.9 million and authorized shares from 150 million to 18.75 million. Post-split shares will begin trading on June 1, 2026 under symbol and new CUSIP.
1. Reverse Split Execution
SCYNEXIS will implement a 1-for-8 reverse stock split at 4:05 p.m. ET on May 29, 2026. At the effective time, every eight shares of common stock will be automatically combined into one share, reducing shares outstanding from approximately 79.5 million to about 9.9 million and authorized shares from 150 million to 18.75 million.
2. Trading on Nasdaq
Split-adjusted shares will begin trading on the Nasdaq Capital Market under SCYNEXIS’s existing symbol with a new CUSIP on June 1, 2026. Share positions held through banks, brokers or other nominees will be adjusted automatically by transfer agent Equiniti Trust Company, LLC, requiring no further action by those holders.
3. Shareholder and Equity Instrument Impacts
The reverse split applies proportionally to all common stock, stock options, restricted stock units and warrants, increasing exercise prices and reducing unit counts on the same 1-for-8 basis. No fractional shares will be issued; holders entitled to fractional interests will receive a cash payment in lieu of fractional shares, and percentage ownership will remain unchanged.
